Cited by 326Nuclear Receptors and SignalingParkinson's Disease Mechanisms and TreatmentsNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 87 of the 89 references it cites were found in a registry or an index.

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

Jankovic, J., Chen, S., Le, W.D.·2005·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2005.09.001

Open this paper in CoChat — free account

Abstract

Nurr1, a transcription factor belonging to the orphan nuclear receptor superfamily, is critical in the development and maintenance of the dopaminergic system and as such it may have role in the pathogenesis of Parkinson' disease (PD). Human Nurr1 gene has been mapped to chromosome 2q22-23 and Nurr1 protein is predominantly expressed in central dopaminergic neurons. Nurr1 interacts with other factors critical for the survival of mensencephalic dopaminergic neurons and it appears to regulate the expression of tyrosine hydroxylase (TH), dopamine transporter (DAT), vesicular monoamine transporter 2 (VMAT2), and l-aromatic amino acid decarboxylase (AADC), all of which are important in the synthesis and storage of dopamine. Experimental studies in Nurr1 knock-out mice indicate that Nurr1 deficiency results in impaired dopaminergic function and increased vulnerability of those midbrain dopaminergic neurons that degenerate in PD. Decreased Nurr1 expression is found in the autopsied PD midbrains, particularly in neurons containing Lewy bodies, as well as in peripheral lymphocytes of patients with parkinsonian disorders. Several variants in Nurr1 gene have been reported in association with PD. All these studies suggest that Nurr1 is not only essential in the development of mensencephalic dopaminergic neurons and maintenance of their functions, but it may also play a role in the pathogenesis of PD.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2005.09.001

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S. K., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,979
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
Kim, J., Auerbach, J. M., Rodríguez‐Gómez, J. A., Velasco, I., Gavin, D. K., Lumelsky, N. L., Lee, S., Nguyen, J., Sánchez‐Pernaute, R., Bankiewicz, K. S., et al. (2002) · Nature · doi:10.1038/nature00900 · Cited by 1,598
Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
Renaud, J., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., & Moras, D. (1995) · Nature · doi:10.1038/378681a0 · Cited by 1,118
Dopamine Neuron Agenesis in Nurr1-Deficient Mice
Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L., & Perlmann, T. (1997) · Science · doi:10.1126/science.276.5310.248 · Cited by 1,096
Derivation of midbrain dopamine neurons from human embryonic stem cells
Perrier, A. L., Tabar, V. S., Barberi, T., Rubio, M. E., Brusés, J. L., Topf, N., Harrison, N. L., & Studer, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404700101 · Cited by 1,007
Parkinson’s Disease and Movement Disorders
Tn, M., & Bhattacharyya, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 802
Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons
Cárdenas, O. S., Quintana-Hau, J. D. D., Le, W., Smidt, M. P., Cox, J. J., Mayo, F. J. D., Burbach, J. P. H., & Conneely, O. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4013 · Cited by 745
Self-citation

Show all 89 references

Research works printed but not linked: 5

Grimes, 2004, A novel mutation in the Nurr1 gene in Parkinson's disease, Mov. Disord., 19, 1120
Jiang, 2004, Effects of ropinirole on progression of parkinsonism in Nurr1 deficient mice and its underlying mechanism, Neurology, 62, A7
Le, 2004, Nurr1 gene targeting therapy for Parkinson's disease, Mov. Dis., 19, S132
Pan, 2005, Reduction of Nurr1 mRNA in human peripheral blood lymphocytes in Parkinson disease, Ann. Neurol.
Pan, 2005, Radicicol induces heat shock protein expression and neuroprotection against rotenone-mediated apoptosis in SH-SY5Y cells, Mov. Dis., S86

Sorted by citations

Items 201–300 of 326

Structure of distress call: implication for specificity and activation of dopaminergic system
Mariappan, S., Bogdanowicz, W., Raghuram, H., Marimuthu, G., & Rajan, K. E. (2015) · Journal of Comparative Physiology A · doi:10.1007/s00359-015-1053-0 · Cited by 16
The N-Terminal Region of Nurr1 (a.a 1–31) Is Essential for Its Efficient Degradation by the Ubiquitin Proteasome Pathway
Alvarez‐Castelao, B., Losada, F., Ahicart, P., & Castaño, J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055999 · Cited by 16
Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
Lai, I., Porcu, A., Romoli, B., Keisler, M. N., Manfredsson, F. P., Powell, S. B., & Dulcis, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044204 · Cited by 14
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons
Chen, Y., Kuang, J., Niu, Y., Zhu, H., Chen, X., So, K., Xu, A., & Shi, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.378203 · Cited by 14
Effects and mechanisms of bisphenols exposure on neurodegenerative diseases risk: A systemic review
Xu, Y., Nie, J., Lu, C., Hu, C., Chen, Y., Ma, Y., Huang, Y., & Lu, L. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170670 · Cited by 14
Lethal Factor Domain-Mediated Delivery of Nurr1 Transcription Factor Enhances Tyrosine Hydroxylase Activity and Protects from Neurotoxin-Induced Degeneration of Dopaminergic Cells
Paliga, D., Raudzus, F., Leppla, S. H., Heumann, R., & Neumann, S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1311-6 · Cited by 14
Applications of Boolean modeling to study the dynamics of a complex disease and therapeutics responses
Hemedan, A. A., Schneider, R., & Ostaszewski, M. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1189723 · Cited by 14
Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models
Fauss, D., Motter, R. N., Dofiles, L., Rodrigues, M. A. V., You, M., Diep, L., Yang, Y., Seto, P., Tanaka, K., Baker, J., et al. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.03.012 · Cited by 14
Neuronal SLC39A8 deficiency impairs cerebellar development by altering manganese homeostasis
Choi, E., Aring, L., Peng, Y., Correia, A. B., Lieberman, A. P., Iwase, S., & Seo, Y. A. (2024) · JCI Insight · doi:10.1172/jci.insight.168440 · Cited by 13
AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders
Liu, K., Yu, J., Zhao, J., Zhou, Y., Xiong, N., Xu, J., Wang, T., Bell, R. L., Qing, H., & Lin, Z. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0781-2 · Cited by 13
Dysregulation of Dopaminergic Regulatory Factors TH, Nurr1, and Pitx3 in the Ventral Tegmental Area Associated with Neuronal Injury Induced by Chronic Morphine Dependence
Shi, W., Zhang, Y., Zhao, G., Wang, S., Zhang, G., Ma, C., Li, Y., & Cong, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020250 · Cited by 13
Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription
Zhang, D., & Heaney, A. P. (2020) · Cells · doi:10.3390/cells9040900 · Cited by 13
α-Synuclein Up-regulates Monoamine Oxidase A Expression and Activity via Trans-Acting Transcription Factor 1
Jia, C., Cheng, C., Li, T., Chen, X., Yang, Y., Liu, X., Li, S., & Le, W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653379 · Cited by 13
Self-citation
Pramipexole attenuates 6-OHDA-induced Parkinson’s disease by mediating the Nurr1/NF-κB pathway
Gao, H., Wang, D., Wang, Y., Mao, J.-P., Jiang, S., & Yang, X. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06343-8 · Cited by 13
Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy
Choi, J.-W., Kang, S. J., Choi, J. I., Kwack, K., & Kim, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052900 · Cited by 13
NURR1 ‐deficient mice have age‐ and sex‐specific behavioral phenotypes
Montarolo, F., Martire, S., Chiara, F., Allegra, S., Francia, S. D., Hoxha, E., Tempia, F., Capobianco, M. A. N., & Bertolotto, A. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25067 · Cited by 13
Recent Advances in Drug Repurposing for Parkinson’s Disease
Chen, X., Gumina, G., & Virga, K. G. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180719144850 · Cited by 13
GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms
Schneider, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119183 · Cited by 13
Polyphenols as Wnt/β‐catenin pathway modulators: A promising strategy in clinical neurodegeneration
Utpal, B. K., Roy, S. C., Zehravi, M., Sweilam, S. H., Raja, A. D., Haque, M. A., Nayak, C., Balakrishnan, S., Singh, L. P., Panigrahi, S., et al. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12525 · Cited by 12
NR4A2 and Dystonia with Dopa Responsiveness
Winter, B., Krämer, J., Meinhardt, T., Berner, D., Alt, K., Wenzel, M., Winkelmann, J., & Zech, M. (2021) · Movement Disorders · doi:10.1002/mds.28701 · Cited by 12
DJ-1/PARK7, But Not Its L166P Mutant Linked to Autosomal Recessive Parkinsonism, Modulates the Transcriptional Activity of the Orphan Nuclear Receptor Nurr1 In Vitro and In Vivo
Lu, L., Zhao, S., Gao, G., Sun, X.-H., Zhao, H., & Yang, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9772-y · Cited by 12
Identification of NURR1 (Exon 4) and FOXA1 (Exon 3) Haplotypes Associated with mRNA Expression Levels in Peripheral Blood Lymphocytes of Parkinson’s Patients in Small Indian Population
Tippabathani, J., Nellore, J., Radhakrishnan, V., Banik, S., & Kapoor, S. (2017) · Parkinson s Disease · doi:10.1155/2017/6025358 · Cited by 12
Structural insights into ligand-binding pocket formation in Nurr1 by molecular dynamics simulations
Windshügel, B. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1559099 · Cited by 12
Liver X receptors agonist promotes differentiation of rat bone marrow derived mesenchymal stem cells into dopaminergic neuron-like cells
Cheng, O., Tian, X., Luo, Y., Mai, S., Yang, Y., Kuang, S., Chen, Q., Ma, J., Chen, B., Li, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23076 · Cited by 11
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Ramachandra, V. H., Sivanesan, S., Koppal, A., Anandakumar, S., Howell, M. D., Sukumar, E., & Vijayaraghavan, R. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0224 · Cited by 12
Assignment of the orphan nuclear receptor Nurr1 by NMR
Michiels, P. J. A., Atkins, K. L., Ludwig, C., Whittaker, S. B. ‐., van Dongen, M. J. P., & Günther, U. L. (2010) · Biomolecular NMR Assignments · doi:10.1007/s12104-010-9210-4 · Cited by 11
Facilitated Neural Differentiation of Adipose Tissue–Derived Stem Cells by Electrical Stimulation and Nurr-1 Gene Transduction
Yang, Y., Ma, T., Ge, J., Quan, X., Yang, L., Zhu, S., Huang, L., Liu, Z., Liu, L., Geng, D., et al. (2016) · Cell Transplantation · doi:10.3727/096368915x688957a · Cited by 11
Possible Roles of Epigenetics in Stem Cell Therapy for Parkinson’s Disease
Thompson, C., Otero, P., Srinageshwar, B., Petersen, R. B., Dunbar, G. L., & Rossignol, J. (2020) · Epigenomics · doi:10.2217/epi-2019-0347 · Cited by 12
Mitochondrial Dysfunction in Parkinson’s Disease: A Contribution to Cognitive Impairment?
Scorziello, A., Sirabella, R., Sisalli, M. J., Tufano, M., Giaccio, L., D’Apolito, E., Castellano, L., & Annunziato, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111490 · Cited by 11
Quantitative Immunohistochemistry to Measure Regional Expression of Nurr1 in the Brain and the Effect of the Nurr1 Heterozygous Genotype
Kummari, E., Guo‐Ross, S. X., Partington, H. S., Nutter, J. M., & Eells, J. B. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.563854 · Cited by 10
The emerging role of miRNA-132/212 cluster in neurologic and cardiovascular diseases: Neuroprotective role in cells with prolonged longevity
Fatimy, R. E., Boulaassafre, S., Bouchmaa, N., Khayari, A. E., Vergely, C., Malka, G., & Rochette, L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111566 · Cited by 12
Neuroreplacement, Growth Factor, and Small Molecule Neurotrophic Approaches for Treating Parkinson's Disease
O’Neill, M. J., Messenger, M. J., Lakics, V., Murray, T. K., Karran, E. H., Szekeres, P. G., Nisenbaum, E. S., & Merchant, K. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77006-4 · Cited by 10
Identification of HIVEP2 as a dopaminergic transcription factor related to substance use disorders in rats and humans
Zhao, J., Chen, C., Bell, R. L., Qing, H., & Lin, Z. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0573-8 · Cited by 10
Inhibition of miR-145-5p Reduces Spinal Cord Injury-Induced Inflammatory and Oxidative Stress Responses via Affecting Nurr1-TNF-α Signaling Axis
Jiang, L., Wei, Z., Xu, L., Yu, S.-Y., & Li, C. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-00992-z · Cited by 10
Parkinson's disease: a long and difficult journey.
Casey, G. (2013) · PubMed · Cited by 10
The Generation of Midbrain Dopaminergic Neurons
Stott, S., & Ang, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397265-1.00099-x · Cited by 10
Evolutionary innovations in the primate dopaminergic system
Doll, H. M., Risgaard, R. D., Thurston, H., Chen, R. J., & Sousa, A. M. M. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102236 · Cited by 10
Epigenetic Regulation of the Ontogenic Expression of the Dopamine Transporter
Green, A. L., Eid, A., Zhan, L., Zarbl, H., Guo, G. L., & Richardson, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01099 · Cited by 10
Adipose tissue derived stromal cells in a gelatin-based 3D matrix with exclusive ascorbic acid signalling emerged as a novel neural tissue engineering construct: an innovative prototype for soft tissue
Martin, C. A., Radhakrishnan, S., Ribelles, J. L. G., Trentz, O. A., Nivethaa, E. A. K., Reddy, M. S., Rela, M., & Kalkura, S. N. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac031 · Cited by 9
Transcriptomic analysis in the striatum reveals the involvement of Nurr1 in the social behavior of prenatally valproic acid-exposed male mice
Kim, H.-J., Woo, R., Yang, E.-J., Kim, H.-B., Jo, E. H., Lee, S., Kim, H.-S., Kim, S., & Kim, H.-S. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02056-z · Cited by 13
Gene Signals and SNPs Associated with Parkinson’s Disease: A Nutrigenomics and Computational Prospective Insights
Subramaniyan, S., Kuriakose, B. B., Mushfiq, S., Prabhu, N. M., & Muthusamy, K. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.10.007 · Cited by 10
Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior
Paquette, M. A., Marsh, S. T., Hutchings, J. E., & Castañeda, E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.01.017 · Cited by 9
Effect of Bushen Huoxue Decoction (补肾活血饮) on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson’s disease
Yang, M., Wang, H.-M., & Liu, Y. (2011) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-011-0618-1 · Cited by 9
“Good” and “Bad” Microglia in Parkinson’s Disease: An Understanding of Homeostatic Mechanisms in Immunomodulation
Tang, Y., & Le, W. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_4 · Cited by 10
Self-citation
Animal models of Parkinson’s disease
Le, W., & Jankovic, J. J. (2013) · doi:10.2217/ebo.13.115 · Cited by 9
Self-citation
RNA- and ATAC-sequencing Reveals a Unique CD83+ Microglial Population Focally Depleted in Parkinson’s DiseasePreprint
Chatila, Z. K., Yadav, A., Mares, J., Flowers, X. E., Yun, T., Rashid, M., Talcoff, R., Pelly, Z., Zhang, Y., Jager, P. L. D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.540842 · Cited by 11
Two novel heterozygous truncating variants in NR4A2 identified in patients with neurodevelopmental disorder and brief literature review
Song, X., Xu, W., Xiao, M., Lu, Y., Lan, X., Tang, X., Xu, N., Yu, G., Zhang, H., & Wu, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.956429 · Cited by 8
Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors
Ho, D. H., Kim, H. J., Nam, D., Seo, M. K., Park, S. W., & Son, I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050263 · Cited by 8
A potential protective role of the nuclear receptor-related factor 1 (Nurr1) in multiple sclerosis motor cortex: a neuropathological study
Pansieri, J., Pisa, M., Yates, R. L., Esiri, M. M., & DeLuca, G. C. (2023) · Brain Communications · doi:10.1093/braincomms/fcad072 · Cited by 9
Dopaminergic Neuronal Conversion from Adult Rat Skeletal Muscle-Derived Stem Cells In Vitro
Yang, J., Wang, X., Wang, Y., Luo, D., Luo, D.-Z., Jia, J., & Wang, X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0819-9 · Cited by 8
Region Specific Effects of Aging and the Nurr1-Null Heterozygous Genotype on Dopamine Neurotransmission
Kummari, E., Guo‐Ross, S. X., & Eells, J. B. (2017) · Neurochemistry & Neuropharmacology · doi:10.4172/2469-9780.1000114 · Cited by 8
Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells
Mallick, S., Marshall, P. A., Wagner, C. E., Heck, M. C., Sabir, Z. L., Sabir, M. S., Dussik, C. M., Grozić, A., Kaneko, I., & Jurutka, P. W. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00707 · Cited by 8
EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area
Wever, I., Wagemans, C. M. R. J., & Smidt, M. P. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00076 · Cited by 8
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells
Alberio, T., Anchieri, C., Piacentini, L., Gentile, G., Simmaco, M., Biasin, M., & Fasano, M. (2011) · Biochimie · doi:10.1016/j.biochi.2011.01.015 · Cited by 7
Pituitary adenylyl cyclase‐activating polypeptide receptor re‐sensitization induces plastic changes in the dopaminergic phenotype in the mature avian retina
Fleming, R. L., Silveira, M. S., Santos, L. E., Henze, I. P., Gardino, P. F., de Mello, M. C. F., & Mello, F. G. D. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12121 · Cited by 8
In vivo expression of Nurr1/Nr4a2a in developing retinal amacrine subtypes in zebrafish Tg(nr4a2a:eGFP) transgenics
Goodings, L., He, J., Wood, A. J., Harris, W. A., Currie, P. D., & Jusuf, P. R. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24185 · Cited by 7
Chiro-Optical Modulation for NURR1 Production from Stem Cells
Patel, M., Moon, H. J., Hong, J. H., & Jeong, B. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00136 · Cited by 7
Genetic Models of Parkinson’s Disease
Kachidian, P., & Gubellini, P. (2020) · Neuromethods · doi:10.1007/978-1-0716-0912-5_3 · Cited by 6
Single-nuclei RNA sequencing uncovers heterogenous transcriptional signatures in Parkinson’s disease associated with nuclear receptor-related factor 1 defect
Kambey, P. A., Liu, W.-Y., Wu, J., Bosco, B., Nadeem, I., Kanwore, K., & Gao, D. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.366493 · Cited by 7
Molecular genetics of Parkinson’s disease
Shadrina, M. I., & Slominsky, P. A. (2006) · Russian Journal of Genetics · doi:10.1134/s1022795406080035 · Cited by 6
Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation
Chandra, J. J., Zhu, Y., Petty, A. E., Kostoglou, Y., Haynes, W. X., Webster, M. J., & Weickert, C. S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03359-7 · Cited by 7
Neural stem cells of the subventricular zone: A potential stem cell pool for brain repair in Parkinson’s disease
Verkerke, M., Werkman, M. H., & Donega, V. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102533 · Cited by 5
Nurr1 deficiency impairs autophagy-lysosomal function through GBA-dependent transcriptional regulation in Parkinson’s disease pathogenesis
Cheng, C., Yang, H., Tian, L., Ni, Y., Jia, C., Le, W., & Wang, Q. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1612389 · Cited by 5
Self-citation
HucMSC extracellular vesicles increasing SATB 1 to activate the Wnt/β‐catenin pathway in 6‐ OHDA ‐induced Parkinson's disease model
He, Y., Li, R., Yu, Y., Xu, Z., Gao, J., Wang, C., Huang, C., & Qi, Z. (2024) · IUBMB Life · doi:10.1002/iub.2893 · Cited by 6
The molecular code involved in midbrain dopaminergic neuron development and maintenance
Perrone‐Capano, C., Volpicelli, F., & di Porzio, U. (2008) · RENDICONTI LINCEI · doi:10.1007/s12210-008-0019-3 · Cited by 5
The effect of different durations of morphine exposure on mesencephalic dopaminergic neurons in morphine dependent rats
Shi, W., Ma, C., Qian, Q., Liu, L., Bi, H., Cong, B., & Li, Y. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.09.005 · Cited by 4
Animal models of Parkinson’s disease and related disorders
Petzinger, G. M., & Jakowec, M. W. (2013) · CRC Press eBooks · doi:10.1201/b14361-17 · Cited by 4
Molecular characterization and analysis of the porcine NURR1 gene
Larsen, K., Momeni, J., Farajzadeh, L., Callesen, H., & Bendixen, C. (2016) · Biochimie Open · doi:10.1016/j.biopen.2016.07.001 · Cited by 4
Movement Disorders
Jankovic, J. J., & Shannon, K. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50113-8 · Cited by 4
Self-citation
Integrated analysis of DNA methylation and RNA-sequencing data in Down syndrome
Zhang, J., Zhou, W., Liu, Y., & Li, N. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5778 · Cited by 4
Expression of the Orphan Nuclear Receptor NR4A in a Putative Adenohypophyseal Homologue of Amphioxus
Candiani, S., Moronti, L., & Pestarino, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03648.x · Cited by 4
Identification and Validation of Inverse Agonists for Nuclear Receptor Subfamily 4 Group A Member 2
Tian, L., Lin, Y., Cheng, C., Yang, H., Qiu, X., Li, S., Jia, C., & Le, W. (2025) · ACS Omega · doi:10.1021/acsomega.5c06698 · Cited by 3
Self-citation
L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.
Kleven, G. A., Booth, H. M., Voogd, M., & Ronca, A. E. (2014) · Behavioral Neuroscience · doi:10.1037/bne0000016 · Cited by 3
Endoplasmic Reticulum Stress Is Associated with the Mesencephalic Dopaminergic Neuron Injury in Stressed Rats
Niu, S., Shi, W., Li, Y., Yi, S., Li, Y., Liu, X., Cong, B., & He, G. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/7852710 · Cited by 3
Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway
Chae, I.-C., Jang, J.-H., Seol, I.-C., Kim, Y.-S., Park, G., & Yoo, H.-R. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7393557 · Cited by 3
Neurochemical Aspects of Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_8 · Cited by 3
Guiding Differentiation of Stem Cells in Vivo by Tetracycline-Controlled Expression of Key Transcription Factors
Kozlova, E. N., & Berens, C. (2012) · Cell Transplantation · doi:10.3727/096368911x637407 · Cited by 4
Parkinson’s Disease: Diagnosis, Motor Symptoms and Non-motor Features
Jankovic, J. J. (2013) · doi:10.2217/9781780843391 · Cited by 4
Self-citation
Nurr1 deficiency shortens free running period, enhances photoentrainment to phase advance, and disrupts circadian cycling of the dopamine neuron phenotype
Partington, H. S., Nutter, J. M., & Eells, J. B. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113347 · Cited by 5
Salt loading as a promising approach to study the dopaminergic phenotype of neurons of the supraoptic nucleus in mice
Bannikova, A., Pronina, T. S., Troshev, D. V., Bogdanov, V. V., Kolacheva, A. A., Pavlova, E., Blokhin, V. E., Kalashnikova, V. I., & Ugrumov, M. V. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340281 · Cited by 2
Cloning, expression, and functional characterization of the rat Pax6 5a orthologous splicing variant
Wei, F., Li, M., Cheng, S., Wen, L., Liu, M., & Shuai, J. (2014) · Gene · doi:10.1016/j.gene.2014.06.032 · Cited by 2
Adult‐Onset Parkinsonism as Late Manifestation of HIVEP2 ‐Associated Developmental Disorder
Badmann, S., Castrop, F., Brügger, M., Winkelmann, J., & Zech, M. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14156 · Cited by 2
Differential roles of NR4A2 ( NURR1 ) paralogs in the brain and behavior of zebrafish
Kalyn, M., Garvey, R., Lee, H., Mbesha, H. A., Curry, J., Saxena, V., Mennigen, J. A., & Ekker, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16234 · Cited by 2
Nrf2 signaling contributes to the neuroprotective effect of Cicadidae Periostracum against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
Lim, H.-S., Moon, B. C., & Park, G. (2022) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v17i1.57472 · Cited by 2
IPX-750, A Dopamine Gluconamine That Binds D1/D5 Receptors and Has Anti-Parkinsonian Effects in Three Animal Models, is Transported across the Blood Brain Barrier
Laine, R. A. (2012) · Journal of Biotechnology & Biomaterials · doi:10.4172/2155-952x.1000142 · Cited by 2
Neuroprotective role of bilirubin in Parkinson's disease
Zhang, Y., Liu, H., Cao, H., Deng, M., Han, Z., Wu, X., Wan, Q., Wang, R., Xu, Y., Lai, J., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1768924 · Cited by 1
A53T α-Synuclein Expression is Associated with Altered Dopaminergic-Like Differentiation and Reduced DNA Topoisomerase IIβ Levels in an In Vitro Model of Parkinson’s Disease
Selim, A., Avşar, T., Neğiş, Y., & Işık, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05881-1 · Cited by 1
Nurr1 deficiency orchestrates a coupled liver–gut pathological axis revealed by multi-omics and deep-learning histopathology
Faisal, S., Ullah, I., Kambey, P. A., Malik, A., Ejaz, M. R., Shah, S. A., & Li, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1861669 · Cited by 1
Vidofludimus calcium for the treatment of multiple sclerosis: development rationale, mechanism of action, and early trial data
Ondrus, M., Fox, R. J., Peelen, E., Fonseca, J., Sciacca, V., Sánchez‐Gómez, I., Arend, J., Herrmann, A., Samcova, M., Gege, C., et al. (2026) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2026.2705509 · Cited by 1
Nurr1: A New Insight to Protects Dopaminergic Neurodegeneration in Parkinson’s disease
(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.436 · Cited by 1
The Possible Protective Role of Dark Chocolate Against Acrylamide Neurotoxicity in Weaning Rats Cerebellum
Hassan, D. M., Welson, N. N., & Yassa, H. D. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02580-x · Cited by 1
Hemiparkinsonism secondary to an epidermoid cyst with complete recovery after surgical resection: Case report and review of the literature
Sarkiss, C. A., Ladner, T. R., Lee, J., Hersh, E. H., Severt, W., MacGowan, D. J. L., & Shrivastava, R. K. (2018) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2018.10.018 · Cited by 1
Orphan nuclear receptor subfamily NR4A their interplay with other nuclear receptors and functions in osteoblasts
Lammi, J. (2008) · Työväentutkimus Vuosikirja · Cited by 1
Defining The Potential Of Gene Therapy With Bone Morphogenetic Proteins As A Novel Therapeutic Approach In Parkinson's Disease
Goulding, S. R. (2021) · doi:10.34719/fhhg1227 · Cited by 1
Structural plasticity of the serotonergic and dopaminergic systems : a multidisciplinary approach
Jahanshahi, A. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120523aj
The proteomic approach to investigate Parkinson's desease: pathogenetic mechanisms and biomarkers discovery.
Alberio, T. (2010) · IrInSubria (University of Insubria)
Efecto de la cocaína sobre el desarrollo y regulación del sistema dopaminérgico en embriones de pez cebra.
Barreto-Valer, K. (2011) · Gredos (University of Salamanca) · doi:10.14201/gredos.115591
Mecanismes de control negatiu de la inflamació vehiculats per receptors nuclears
Borrel, J. M., & Valledor, A. F. (2014) · Estudis Romànics (Institut d'Estudis Catalans) · doi:10.2436/tscb.v65i0.136719
On the influence of dopamine-related genetic variation on dopamine-related disorders
Bergman, O. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
The Pitx3-deficient aphakia mouse: a naturally occurring mouse model of dopamine deficiency
van den Munckhof, P. (2011) · UvA-DARE (University of Amsterdam)

Authors: Jankovic, J., Chen, S., & Le, W. D.
Affiliations: Baylor College of Medicine (US)
Shanghai Jiao Tong University (CN)
Corresponding author: Le, W.D.
ORCID: Jankovic, J.
Chen, S.
Le, W.D.
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2005-09
Volume: 77
Issue: 1-2
Pages: 128-138
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2005.09.001
OpenAlex: W2048841722
Cited by: 325
References: 89
Citations by year: 2026: 10 · 2025: 8 · 2024: 15 · 2023: 14 · 2022: 21 · 2021: 22 · 2020: 13 · 2019: 19 · 2018: 13 · 2017: 19 · 2016: 15 · 2015: 18 · 2014: 16 · 2013: 22 · 2012: 16
FWCI: 1.06
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Neurological Disorders and Stroke (NS043567, R01NS043567, NS40370, R01NS040370)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: Nurr1, Parkinson's disease, dopaminergic neurons, midbrain, transcription factors, orphan nuclear receptor, tyrosine hydroxylase, dopamine transporter, vesicular monoamine transporter 2, aromatic L-amino acid decarboxylase, Lewy bodies, dopaminergic neuron development, dopaminergic neuron survival
MeSH terms: Animals, Brain, Cell Differentiation, DNA-Binding Proteins, Dopamine, Humans, Neurons, Parkinson Disease, Transcription Factors, Signal Transduction, Nuclear Receptor Subfamily 4, Group A, Member 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks